online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
  • 5 of 14
ECPB 2018, 83(3): 33–39
Research articles

Canonical Wnt-Signaling Activity During the Athletic Heart Formation


Introduction. The heart is the organ which is formed in embryogenesis and has been working for all life. Widely known, that myocardium is able to adapt to many types of stress factors (physical and biological), these adaptations are supported by changes at the morphological, biochemical and molecular genetic levels. Heart remodeling is driven by many of signaling pathways and molecules. To understand the signaling pathway involvement in the regulation of adult heart remodeling is crucial for the heart biological development as well as for clinicians. One of such signaling mechanism is canonical Wnt or Wnt/β-catenin signaling which is involved in cardiogenesis and adult heart remodeling. The requirements for canonical Wnt and β-catenin for heart hypertrophy are not fully understood and controversial. Many transgenic and knockout mice models were used for studying the canonical Wnt role in adult heart remodeling. Some authors suggested that canonical Wnt and β-catenin are not essential for the hypertrophic response; but others showed involvement of this signaling pathway in the heart hypertrophy. The function of canonical Wnt in the athletic heart formation is not clear and has not been analyzed yet.

Purpose. Here we have focused on the analysis of canonical Wnt signaling during adult heart adaptation to physical training. With mice model and molecular genetic methods (qPCR), we have analyzed heart adaptation (Anp and Bnp genes expression level).

Materials and methods. The activity of canonical Wnt was studied after 1 week and 1 month of training: Axin2 and c-Myc genes expression as well as the level of phosphorylated GSK3β protein were analyzed (with Western-blot using). In this work we have used a standard swimming test for hypertrophic response induction. As a result of our experiment, we have registered the higher level of Anp and Bnp genes expression in mice hearts after 1 month of experiment that is remarkable for the heart hypertrophy.

Results. It is interesting that hypertrophic genes were expressed at the lower level after 1 week of training as compared with the control group and 1 month of exercises. The analysis of HW/BW index in the connection with these data has supported the hypertrophy response in trained mice after one month. Thus, the obtained data have clearly indicated the heart hypertrophy development in mice after 1 month of swimming. On the other hand, the histological analysis (hematoxylin-eosin and Van Gison staining) of paraffin embedded transversional heart sections has not revealed any morphological malformations or/and heart tissue fibrosis in the trained heart after 1 week as well as 1 month of experiment. Thus, we can assume that in our model we have developed the physiological hypertrophy in mice. For recovering of canonical Wnt involvement in the heart adaptation we have analyzed the level of β-catenin target genes expression with qPCR usage. Also we have checked the level of total and phosphorylated GSK3β protein - the main component of β-catenin degradation complex. We have found out the increase of Axin2 gene expression after 1 week and the decrease after 1 month of training. The higher level of phosphorylated GSK3β protein after 1 week of experiment also suggested the canonical Wnt signaling activation in hearts after 1 week of exercises and the downregulation after 1 month of training. It is known that higher level of phosphorylated GSK3β is correlated with the activated β-catenin level.

Conclusions. Thus, our data demonstrated that canonical Wnt is required on early stages of heart remodeling. We can suppose that canonical Wnt signaling was downregulated later, after hypertrophic genetic program activation via negative feedback signaling in cells.

Article recieved: 28.08.2018

Keywords: β-catenin, hypertrophy, Wnt signaling, athletic myocardium adaptation

Full text: PDF (Ukr) 336K

  1. 1. Barry SP, Davidson SM, Townsend PA. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol. 2008; 40(10): 2023-39.
  2. 2. Qu J, Zhou J, Yi XP, Dong B, Zheng H, Miller LM et al. Cardiac specific happloinsufficiency of beta-cateninc attenuates cardiac hypertrophy but enhances fetal genes expression in response to aortic constriction. Molecular Cell. 2007; 43(3):319-26.
  3. 3. Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C et al. β-catenin downregulation is required for adaptive cardiac remodeling anthony. Circulation Research. 2007;100(9):1353-62.
  4. 4. Evangelista FS, Brum PC, Krieger JE. Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz J Med Biol Res. 2003;36(12):1751-9.
  5. 5. Kontaridis MI, Geladari EV, Geladari CV. Pathways to Myocardial Hypertrophy. Introduction to Translational Cardiovascular Research. 2014;167-86.
  6. 6. Palchevska OL, Macewicz LL, Piven OO. A link between β-catenin and hypertrophy: evaluation and meta-analysis. Biopolymers and Cell. 2016;32(2):150-7.
  7. 7. Chen X, Shevtsov SP, Hsich E, Cui L, Haq S, Aronovitz M et al. The β-catenin/t-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Molecular and Cellular Biology. 2006; 26(12):4462-73.
  8. 8. Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L et al. Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO Journal. 2012;31(2):429-42.
  9. 10. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (gsk3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target, a critical analysis. British Journal of Pharmacology. 2008;1:137-53.
  10. 11. Zelarayan LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A et al. β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proceedings of the National Academy of Sciences. 2008;105(50):19762-7. http
  11. 12. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: еxperimental findings and therapeutic strategies. Pharmacology & Therapeutics. 2010; 128(1):191-227.
  12. 13. Piven OO, Winata CL. The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling. Experimental Biology and Medicine. 2017; 242(18):1735-45.
  13. 14. Piven OO. Vazhlyvist syhnalnoi funktsii β-kateninu na pochatkovykh stadiiakh rozvytku patolohichnoi hipertrofii dorosloho sertsia. Visnyk Ukrainskoho Tovarystva Henetykiv i Selektsioneriv. 2016; 14(1):44-51.
  14. 15. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory Press, 2003.
  15. 16. Oerlemans MI, Goumans J, van Middelaar B, Clevers H, Doevendans PA, Sluijter JP. Active wnt signaling in response to cardiac. Basic Research in Cardiology. 2010;105(5):631-41.
  16. 17. Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS et al. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension. 2010;55(4):939-45.
  17. 18. Barandon L, Couffinhal T, Ezan J, Dufourcq P, Costet P, Alzieu P et al. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing frza. Circulation. 2003;108(18):2282-9.
  18. 19. Li J, Swope D, Raess N, Cheng L, Muller EJ, Radice GL. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of beta-catenin signaling. Mol Cell Biol. 2011;31(6):1134-44.
  19. 20. Brade T, Manner J, Kuhl M. The role of Wnt signalling in cardiac development and tissue remodeling in the mature heart. Cardiovasc. Res. 2006;72(2):198-209.
  20. 21. Filipovich A, Gehrke I, Poll-Wolbeck SJ, Kreuzer KA. Physiological inhibitors of wnt signaling. European Journal of Haematology. 2011;86(6):453-65. http
  21. 22. Hahn JY, Cho HJ, Bae JW, Yuk HS, Kim KI, Park KW et al. β-Catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. Journal of Biological Chemistry. 2006;281(41):30979-89.

Програмування -